Envoy Medical Files 8-K

Ticker: COCHW · Form: 8-K · Filed: Dec 16, 2025 · CIK: 1840877

Sentiment: neutral

Topics: corporate-update, filing

TL;DR

Envoy Medical (formerly Anzu Special Acquisition Corp I) updated its corporate info on 12/16/25.

AI Summary

Envoy Medical, Inc. filed an 8-K on December 16, 2025, reporting on its current activities. The filing indicates the company's principal executive offices are located at 4875 White Bear Parkway, White Bear Lake, MN 55110. The company was formerly known as Anzu Special Acquisition Corp I until a name change on January 15, 2021.

Why It Matters

This 8-K filing provides an update on Envoy Medical, Inc.'s corporate status and location, which is important for investors and stakeholders to track the company's official information.

Risk Assessment

Risk Level: low — This filing is a routine corporate update and does not contain significant financial or operational news that would inherently increase risk.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Envoy Medical, Inc.?

The primary purpose is to report current information as required by the Securities Exchange Act of 1934, specifically noting the date of the earliest event reported as December 16, 2025, and providing details about the company's location and former name.

When did Envoy Medical, Inc. change its name from Anzu Special Acquisition Corp I?

Envoy Medical, Inc. changed its name from Anzu Special Acquisition Corp I on January 15, 2021.

What is the address of Envoy Medical, Inc.'s principal executive offices?

The address of Envoy Medical, Inc.'s principal executive offices is 4875 White Bear Parkway, White Bear Lake, MN 55110.

What is the SEC file number for Envoy Medical, Inc.?

The SEC file number for Envoy Medical, Inc. is 001-40133.

What is the IRS Employer Identification Number (EIN) for Envoy Medical, Inc.?

The IRS Employer Identification Number (EIN) for Envoy Medical, Inc. is 86-1369123.

Filing Stats: 593 words · 2 min read · ~2 pages · Grade level 11.9 · Accepted 2025-12-16 09:47:46

Key Financial Figures

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure Envoy Medical, Inc. (the "Company") is furnishing its updated Investor Presentation (the "Investor Presentation") that management of the Company intends to use, possibly with modifications, in one or more meetings from time to time with current and potential investors. The foregoing description of the Investor Presentation does not purport to be complete and is qualified in its entirety by reference to the complete text of the Investor Presentation attached as Exhibit 99.1 to this Current Report on Form 8-K. The Investor Presentation contains forward-looking statements. See Page 2 of the Investor Presentation for a discussion of certain forward-looking statements that are included therein and the risks and uncertainties related thereto. The information set forth in this Item 7.01 of this Report, including without limitation the Investor Presentation, is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as may be expressly set forth by specific reference in such a filing. Item9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Investor Presentation. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 1

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ENVOY MEDICAL, INC. December 16, 2025 By: /s/ Brent T. Lucas Brent T. Lucas Chief Executive Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing